drugset / Trial / NCT04409132
Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
RandomizedSequentialOpen-labelTreatment
Summary
This study will investigate the administration of Triferic AVNU intravenously by three different administration schedules compared to continuous infusion over 3 hours
Timeline
- Start
- 2020-06-25
- Primary completion
- 2021-04-02
- Completion
- 2021-04-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triferic | Other / unclassified | 0.08 mg/kg | Intravenous |
| Subject | Triferic | Other / unclassified | 2.25 mg | Intravenous |
| Subject | Triferic | Other / unclassified | 3.4 mg | Intravenous |
| Subject | Triferic | Other / unclassified | 6.75 mg | Intravenous |